InvestoGain

Investogain Pty Limited
AFS Licence No. 334036

All correspondence to:
admin@delisted.com.au
or by mail to:
PO Box 400
Crows Nest NSW 1585

26 April 2025

Name:	SCIGEN LIMITED (SIE)
Date of Listing:	15 November 2002
Date of Delisting:	28 August 2018

Stock Exchange Status: (updated daily)

This entity was delisted from the Australian Securities Exchange on 28 August 2018.

Legal Status: (updated monthly)

To our knowledge this entity was the subject of a takeover or merger such that your securities were acquired for consideration in the form of cash or scrip. We have not therefore verified the current legal status of this entity. If you have questions about your shareholding, as we say elsewhere, they may be taken up here: https://www.delisted.com.au/TraceLostSharesLostMoney/index/.

Capital Gains Tax (CGT) Status: (updated at least quarterly)

To our knowledge this entity was the subject of a takeover or merger such that your securities were acquired for consideration in the form of cash or scrip. You will need to seek independent tax advice in relation to Capital Gains Tax or other tax matters but any other enquiries relating to your shareholding in the company should be followed up via our online form here: https://www.delisted.com.au/TraceLostSharesLostMoney/index/.

Updates, corrections, disagreements please email to admin@delisted.com.au

Further information: deListed and InvestoGain are operated by Investogain Pty Limited which is licensed by ASIC as an Australian Financial Services Licensee (AFSL 334036). deListed acquires only securities that it deems to be of little or no value, in circumstances where the holder is unable to sell their securities on-market in the normal manner. This service has been provided online via the company’s website www.delisted.com.au since 2004.

Getting advice: Information provided in this section is of a general nature and applicable only to Australian tax residents who hold their investments on capital account (ie for long-term investment purposes). It has been prepared without taking into account your financial needs or tax situation. Before acting on the information, deListed suggests that you consider whether it is appropriate for your circumstances and recommends that you seek independent legal, financial, or taxation advice.

Disclaimer: The information provided above is to the best of our knowledge accurate as of today. But you should bear in mind that it is of a general nature and does not constitute financial or tax advice. Investogain Pty Limited accepts no liability for any loss arising from reliance on this information, including reliance on information that is no longer current.

SCIGEN LIMITED(SIE)

Click here for free access to this company's:
ASX, Legal & CGT Status

Former (or subsequent) names

Shareholder links

Our website ranking of SIE:

(4 out of 5)

COMPANY WEBSITE:

SIE website

SIE email

SIE investorRelations

SIE announcements

SIE directors

REGISTRY:

Level 5, 115 Grenfell Street, Adelaide SA 5000

Tel : +61 (0)3 9415 4000 or 1300 850 505 (within Australia)
Fax : +61 8 9473 2408 or 1300 534 987
RegistryWebsite RegistryEmail

Company details

Address: Suite 1, 13B Narabang Way, BELROSE, NSW, AUSTRALIA, 2085
Tel: 02-9485-1800 Fax: 02-9485-1888

Date first listed: 15/11/2002
Company Secretary:
Sector: Pharmaceuticals & Biotechnology Industry Group: XHJ
Activities: Biopharmaceutical company that manufactures and delivers healthcare products globally - its focus is in the areas of endocrinology and immunology and its product portfolio includes vaccines and therapeutics

News & Events

Expand this box to read and print

delisted from the close of trading on Tuesday, 28 August 2018 pursuant to Listing rule 17.14.	28/08/2018
we understand SAC Capital Private Limited was successful with an offer of US$0.0507 cash per Scigen share	28/08/2018
the suspension of trading in the securities of SciGen Limited (the "Company") will be lifted on the commencement of trading on Friday, 3 April 2009, following receipt of the Company's Full Year Accounts for the period ended 31 December 2008, in accordance with listing rule 17.8	02/04/2009
shares suspended from quotation following failure to lodge full year accounts	01/04/2009
with regard to the demerger in December 2002, Sonic shareholders received one SciGen share in the form of a CUFS for every Sonic share held - Sonic advised the Australian Taxation Office that SciGen represented 0.66% of the market value of the group as a whole just after the demerger - according to the Australian Tax Office shareholders who received SciGen shares should use this percentage to apportion the sum of the cost bases of their post-CGT Sonic shares between these shares and the post-CGT SciGen shares	31/12/2002

ASX Announcements (courtesy of ASX)

Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.

Company Updates

Post your comments here

Please read our Terms before posting comments.

Click here for free access to this company's:
ASX, Legal & CGT Status

Directors' on-market share transactions (last 5)

Click here for the last 20 transactions all companies

Directors & Executives (current)

NAME	TITLE	DATE OF APPT
Slawomir Ziegert	Executive Chairman, CEO	01/12/2009
Mateusz Kosecki	Non Exec Director	01/12/2009
Marcin Dukaczewski	Non Exec Director	26/12/2008
Yvonne Lim	Executive Director	08/09/2017
Zou Jun	Director	07/08/2018
Yanzhi Shi	Director	08/08/2018
Kang Yun	Director	07/08/2018

Date of first appointment, title may have changed.

Directors & Executives (former)

NAME	TITLE	DATE OF APPOINTMENT	DATE OF RESIGNATION

Date of first appointment, title may have changed.